GRN and Alzheimer disease: PGRN overexpression is protective in animal models of AD.547 Small molecule like ZAP2006 and monoclonal antibody like AL101 that can enhance the expression of PGRN have been developed and undergoing clinical trials for the treatment of AD (clinicaltrials.gov).